文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

新型冠状病毒肺炎患者使用体外膜氧合后一年功能、认知和心理结局:一项前瞻性研究

One-Year Functional, Cognitive, and Psychological Outcomes Following the Use of Extracorporeal Membrane Oxygenation in Coronavirus Disease 2019: A Prospective Study.
PubMed 文献 · Crit Care Explor · 2021-09-10
一句话结论COVID-19接受ECMO幸存者1年时功能损害常见但多数日常生活独立,焦虑抑郁和PTSD常见而认知损害不常见。

1年随访时中位改良Rankin量表评分为2分(IQR 1-2),中位WHODAS 2.0损害评分为21%(IQR 6-42%);12名既往就业者中6人(50%)重返工作,12人中10人(83%)日常生活完全独立。10例接受筛查者中4例(40%)抑郁、6例(60%)焦虑、4例(40%)PTSD筛查阳性;中位5分钟MoCA评分为14分(IQR 13-14)。

要点

  • 1年时中位改良Rankin量表评分为2分(IQR 1-2),中位WHODAS 2.0损害评分为21%(IQR 6-42%),功能损害常见。
  • 12名既往就业者中6人(50%)重返工作,12人中10人(83%)日常生活完全独立。
  • 10例接受HADS筛查者中4例(40%)抑郁、6例(60%)焦虑筛查阳性;10例中4例(40%)PTSD筛查阳性。
  • 中位5分钟MoCA评分为14分(IQR 13-14),认知损害不常见;1例1年时依赖机械通气,另1例间断需要补充氧气。

适用人群与场景

  • 2020年3月1日至7月31日美国一家三级ECMO中心收治的接受ECMO治疗的成人COVID-19急性呼吸窘迫综合征患者。

诊断标准与关键阈值

  • 功能结局采用改良Rankin量表评估,中位评分2分(IQR 1-2)。
  • 功能损害采用世界卫生组织残疾评定量表2.0评估,中位损害评分21%(IQR 6-42%)。
  • 认知状态采用5分钟蒙特利尔认知评估评估,中位评分14分(IQR 13-14)。
  • 焦虑和抑郁采用医院焦虑抑郁量表筛查。
  • 创伤后应激障碍采用创伤后应激障碍检查表5筛查。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 1年随访时1例患者依赖机械通气,另1例间断需要补充氧气。
  • 10例接受筛查者中4例(40%)抑郁筛查阳性、6例(60%)焦虑筛查阳性、4例(40%)PTSD筛查阳性。

研究设计与关键结果

  • 1年时中位改良Rankin量表评分为2分(IQR 1-2),中位WHODAS 2.0损害评分为21%(IQR 6-42%)。
  • 12名既往就业者中6人(50%)重返工作,12人中10人(83%)日常生活完全独立。
  • 中位5分钟MoCA评分为14分(IQR 13-14)。
  • 10例接受HADS筛查者中4例(40%)抑郁筛查阳性、6例(60%)焦虑筛查阳性;10例中4例(40%)PTSD筛查阳性。

证据类型、等级与局限

  • 证据类型为前瞻性病例系列(单中心、样本量小)。

对床旁实践的改变

  • 对接受ECMO的COVID-19 ARDS幸存者,出院后1年应关注功能损害、焦虑、抑郁和PTSD筛查,原文显示这些结局常见。
  • 原文显示认知损害不常见,但中位5分钟MoCA评分为14分(IQR 13-14),原文未给出该评分的判读阈值。
  • 原文未提及具体干预措施,不能据此改变ECMO管理或康复方案。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

UNLABELLED: To prospectively describe 1-year outcomes, with a focus on functional outcome, cognitive outcome, and the burden of anxiety, depression, and post-traumatic stress disorder, in coronavirus disease 2019 patients managed with extracorporeal membrane oxygenation.

DESIGN: Prospective case series.

SETTING: Tertiary extracorporeal membrane oxygenation center in the United States.

PATIENTS: Adult coronavirus disease 2019 acute respiratory distress syndrome patients managed with extracorporeal membrane oxygenation March 1, 2020, to July 31, 2020.

INTERVENTIONS: Baseline variables, treatment measures, and short-term outcomes were obtained from the medical record. Survivors were interviewed by telephone, a year following the index intensive care admission. Functional outcome was assessed using the modified Rankin Scale and the World Health Organization Disability Assessment Scale 2.0. Cognitive status was assessed with the 5-minute Montreal Cognitive Assessment. The Hospital Anxiety and Depression Scale was used to screen for anxiety and depression. Screening for post-traumatic stress disorder was performed with the Posttraumatic Stress Disorder Checklist 5 instrument.

MEASUREMENTS AND MAIN RESULTS: Twenty-three patients were managed with extracorporeal membrane oxygenation, 14 (61%) survived to hospital discharge. Thirteen (57%) were alive at 1 year. One patient was dependent on mechanical ventilation, another intermittently required supplemental oxygen at 1 year. The median modified Rankin Scale score was 2 (interquartile range, 1-2), median World Health Organization Disability Assessment Scale 2.0 impairment score was 21% (interquartile range, 6-42%). Six of 12 previously employed individuals (50%) had returned to work, and 10 of 12 (83%) were entirely independent in activities of daily living. The median Montreal Cognitive Assessment score was 14 (interquartile range, 13-14). Of 10 patients assessed with Hospital Anxiety and Depression Scale, 4 (40%) screened positive for depression and 6 (60%) for anxiety. Four of 10 (40%) screened positive for post-traumatic stress disorder.

CONCLUSIONS: Functional impairment was common a year following the use of extracorporeal membrane oxygenation in coronavirus disease 2019, although the majority achieved independence in daily living and about half returned to work. Long-term anxiety, depression, and post-traumatic stress disorder were common, but cognitive impairment was not.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Rajajee V, Fung CM, Seagly KS, et al. One-Year Functional, Cognitive, and Psychological Outcomes Following the Use of Extracorporeal Membrane Oxygenation in Coronavirus Disease 2019: A Prospective Study. Crit Care Explor. 2021. PMID: 34589715. doi:10.1097/CCE.0000000000000537

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。